Delgado Sigfrido 4

What Happened

• Sigfrido Delgado, Senior Vice President of Operations at Avanos Medical (AVNS), surrendered 4,264 shares to the company to satisfy tax-withholding obligations tied to the vesting of time‑based RSUs. The shares were valued at $24.64 each, totaling $105,065. This was a tax-withholding disposition (not an open‑market sale).

Key Details

• Transaction date: April 22, 2026; Filing date: April 24, 2026 (no indication in the filing that it was late).
• Disposed/surrendered: 4,264 shares at $24.64 per share for a total of $105,065.
• Vesting detail: 16,300 time‑based restricted share units (TRSUs) were awarded on April 22, 2025 and vested on April 22, 2026; each TRSU equals one share.
• Net shares retained from the vesting: 16,300 vested − 4,264 surrendered = 12,036 shares (received after withholding).
• Transaction code F denotes shares surrendered to cover tax withholding (not a sale under market code S).
• Shares owned after the transaction are not explicitly reported in the Form 4 filing.

Context

• This is a routine tax‑withholding action upon RSU vesting and should not be interpreted as an insider selling shares in the open market. Such withholdings are common and don’t necessarily signal the insider’s view on the company. Purchases or open‑market sales generally carry more information about insider sentiment than tax withholdings.